Polypill strategy succeeds in preventing major cardiovascular events
11 Nov 2019
bởiJairia Dela Cruz
Use of a polypill or fixed-dose combination of aspirin, atorvastatin, hydrochlorothiazide and enalapril appears to effectively cut the risk of major cardiovascular events, with high adherence and low adverse event (AE) rates, in individuals aged 50–75 years in a real-life setting, according to data from the PolyIran trial.